GridAI Technologies Corp.

Healthcare · Biotechnology · United Kingdom

Last price 4.97 USD (Oct 30, 2026, 3:13 PM EDT) · Market cap 35.19M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.